MAIN CONTENT
Regulatory approval shocks and the institutional legal revolt from CME
The push by federal regulators under the Trump administration to domesticate novel offshore perpetual futures has fractured relations between Washington and traditional financial exchange operators. CME Group, the world's preeminent derivatives exchange, launched a historic lawsuit against the Commodity Futures Trading Commission (CFTC) to vacate its May decision, swiftly joined by Cboe Global Markets and market maker Citadel Securities in challenging subsequent approvals for single-stock equity perps.
At the core of the dispute is the statutory classification of the financial instrument. Legacy exchanges argue that because perpetual contracts do not expire and rely on continuous periodic funding payments between long and short counterparties, they legally constitute 'swaps' under the 2010 Dodd-Frank Wall Street Reform Act. Regulating them under more lenient futures frameworks deprives retail investors of mandatory capital buffers, stringent margin disclosures, and comprehensive counterparty protections.
"I think they have muddied the waters here significantly, and anytime you introduce ambiguity into markets, that directly hurts sustainable commercial enterprise" Terry Duffy, Chief Executive Officer of CME Group.
















